Horizon Oncology Research, Inc — Lafayette, Indiana

Horizon Oncology Research, Inc is a clinical research site located in Lafayette, Indiana, United States 47905.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Horizon Oncology Research, Inc has participated in 8 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Merrimack Pharmaceuticals, Celgene Corporation.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Horizon Oncology Research, Inc?

Horizon Oncology Research, Inc has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Horizon Oncology Research, Inc conducted?

Horizon Oncology Research, Inc has 8 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is Horizon Oncology Research, Inc accredited by Crixeo Health?

Yes — Horizon Oncology Research, Inc holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Horizon Oncology Research, Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.